Lins, Brittney R.
Anyaegbu, Chidozie C.
Hellewell, Sarah C.
Papini, Melissa
McGonigle, Terence
De Prato, Luca
Shales, Matthew
Fitzgerald, Melinda
Funding for this research was provided by:
MediCann Health Aust Pty Ltd
Article History
Received: 11 July 2022
Accepted: 13 February 2023
First Online: 19 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: This was an industry-sponsored project. Funding from MediCann Health Aust Pty Ltd included salary support for BRL during the tenure of this project. MS is the CEO of MediCann Health Aust Pty Ltd. LDP is a Director of MediCann Health Aust Pty Ltd. MF is the CEO of Connectivity Traumatic Brain Injury Australia. All other authors declare that they have no competing interests.